273 related articles for article (PubMed ID: 34407811)
1. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial.
Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
BMC Med; 2021 Aug; 19(1):183. PubMed ID: 34407811
[TBL] [Abstract][Full Text] [Related]
2. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia: A Randomized Clinical Trial.
Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
JAMA Intern Med; 2021 Feb; 181(2):168-178. PubMed ID: 33136119
[TBL] [Abstract][Full Text] [Related]
4. Treatment of periodontitis for glycaemic control in people with diabetes mellitus.
Simpson TC; Clarkson JE; Worthington HV; MacDonald L; Weldon JC; Needleman I; Iheozor-Ejiofor Z; Wild SH; Qureshi A; Walker A; Patel VA; Boyers D; Twigg J
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD004714. PubMed ID: 35420698
[TBL] [Abstract][Full Text] [Related]
5. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
van den Burg EL; Schoonakker MP; van Peet PG; van den Akker-van Marle EM; Lamb HJ; Longo VD; Numans ME; Pijl H
Diabetologia; 2024 Jul; 67(7):1245-1259. PubMed ID: 38546821
[TBL] [Abstract][Full Text] [Related]
6. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.
Bergenstal RM; Johnson M; Passi R; Bhargava A; Young N; Kruger DF; Bashan E; Bisgaier SG; Isaman DJM; Hodish I
Lancet; 2019 Mar; 393(10176):1138-1148. PubMed ID: 30808512
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
9. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
11. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
13. Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching.
Odnoletkova I; Goderis G; Nobels F; Fieuws S; Aertgeerts B; Annemans L; Ramaekers D
Diabet Med; 2016 Jun; 33(6):777-85. PubMed ID: 26872105
[TBL] [Abstract][Full Text] [Related]
14. A carbohydrate-reduced high-protein diet improves HbA
Skytte MJ; Samkani A; Petersen AD; Thomsen MN; Astrup A; Chabanova E; Frystyk J; Holst JJ; Thomsen HS; Madsbad S; Larsen TM; Haugaard SB; Krarup T
Diabetologia; 2019 Nov; 62(11):2066-2078. PubMed ID: 31338545
[TBL] [Abstract][Full Text] [Related]
15. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock J; Frias J; Jastreboff AM; Du Y; Lou J; Gurbuz S; Thomas MK; Hartman ML; Haupt A; Milicevic Z; Coskun T
Lancet; 2023 Aug; 402(10401):529-544. PubMed ID: 37385280
[TBL] [Abstract][Full Text] [Related]
16. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
Rosenstock J; Wysham C; Frías JP; Kaneko S; Lee CJ; Fernández Landó L; Mao H; Cui X; Karanikas CA; Thieu VT
Lancet; 2021 Jul; 398(10295):143-155. PubMed ID: 34186022
[TBL] [Abstract][Full Text] [Related]
19. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial.
Mayer-Davis EJ; Maahs DM; Seid M; Crandell J; Bishop FK; Driscoll KA; Hunter CM; Kichler JC; Standiford D; Thomas JM;
Lancet Child Adolesc Health; 2018 Sep; 2(9):635-646. PubMed ID: 30119757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
